Başak KARAKURUM GÖKSEL, Şenay DEMİR, Tülin YILDIRIM, Meliha TAN, Naime TOKMAK

Evaluation of brain perfusion in Alzheimer disease with perfusion computed tomography and comparison to elderly patient without dementia

Background/aim: The aim of this study was to evaluate perfusion computed tomography (PCT) findings in patients with Alzheimer disease and to compare them with those of patients without dementia. Materials and methods: PCT was performed in 35 patients: 20 with Alzheimer disease (mean age, 69.7 ± 5.5 years) and 15 control subjects (mean age, 67.5 ± 3.5 years). Control subjects were elderly individuals with no cognitive problems who were admitted with headaches. All PCT examinations were performed on a 4-slice CT unit. The PCT analysis software program was used to calculate regional cerebral blood flow (rCBF), regional cerebral blood volume (rCBV), regional time-to-peak (rTTP) values in the bilateral frontal, temporal, and occipital cortices, and bilateral lentiform nucleus. Results: rCBF values in the bilateral frontal and temporal cortices and bilateral lentiform nucleus were significantly lower in the patients with Alzheimer disease than in the control subjects. There were no significant differences in rCBV values between Alzheimer disease and the control group. rTTP values in all cortical areas and bilateral lentiform nucleus were significantly higher in the patients with Alzheimer disease than in the control subjects. Conclusion: PCT is a rapid and reliable imaging modality for evaluating brain perfusion in Alzheimer disease.

PDF

___

1. Golden R. Dementia and Alzheimers disease. Indications, diagnosis, and treatment. Minn Med 1995; 78: 25-29.
2. Bennett DA, Evans DA. Alzheimers disease. DM-Dis Mon 1992; 38: 1-64.
3. Caroli A, Testa C, Geroldi C, Nobili F, Barnden LR, Guerra UP, Bonetti M, Frisoni GB. Cerebral perfusion correlates of conversion to Alzheimers disease in amnestic mild cognitive impairment. J Neurol 2007; 254: 1698-1707.
4. Matsuda H. The role of neuroimaging in mild cognitive impairment. Neuropathology 2007; 27: 570-577.
5. Scheltens P, Korf ES. Contribution of neuroimaging in the diagnosis of Alzheimers disease and other dementias. Curr Opin Neurol 2000; 13: 391-396.
6. Zimny A, Sasiadek M, Leszek J, Czarnecka A, Trypka E, Kiejna A. Does perfusion CT enable differentiating Alzheimers disease from vascular dementia and mixed dementia? A preliminary report. J Neurol Sci 2007; 257: 114-120.
7. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimers disease: report of the NINCDS-ADADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimers Disease. Neurology 1984; 34: 939-944.
8. Diagnostic patterns of regional atrophy on MRI and regional cerebral blood flow change on SPECT on SPECT in young onset patients with Alzheimers disease, frontotemporal dementia and vascular dementia. Acta Neurol Scand 2002; 105: 261-269.
9. Kantarci K. H magnetic resonance spectroscopy in dementia. Brit J Radiol 2007; 80: 146-152.
10. Callen DJ, Black SE, Gao F, Caldwell CB, Szalai JP. Beyond the hippocampus: MRI volumetry confirms widespread limbic atrophy in Alzheimer disease. Neurology 2001; 57: 1669-1674.
11. Yoshikawa T, Murase K, Oku N, Imaizumi M, Takasawa M, Rishu P, Kimura Y, Ikejiri Y, Kitagawa K, Hori M, et al. Heterogeneity of cerebral blood flow in Alzheimer disease and vascular dementia. Am J Neuroradiol 2003; 24: 1341-1347.
12. Hanyu H, Shimizu S, Hirao K, Kanetaka H, Sakurai H, Iwamoto T, Koizumi K, Abe K. Differentiation of dementia with Lewy bodies from Alzheimers disease using Mini Mental State Examination and brain perfusion SPECT. J Neurol Sci 2006; 250: 97-102.
13. Du AT, Jahng GH, Hayasaka S, Kramer JH, Rosen HJ, GornoTempini ML, Rankin KP, Miller BL, Weiner MW, Schuff N. Hypoperfusion in frontotemporal dementia and Alzheimer disease by arterial spin labeling MRI. Neurology 2006; 67: 1215-1220.
14. Nagga K, Radberg C, Marcusson J. CT brain findings in clinical dementia investigation -underestimation of mixed dementia. Dement Geriatr Cogn 2004; 18: 59-66.
15. Hoeffner EG, Case I, Jain R, Gujar SK, Shah GV, Deveikis JP, Carlos RC, Thompson BG, Harrigan MR, Mukherji SK. Cerebral perfusion CT: technique and clinical applications. Radiology 2004; 231: 632-644.
16. Missler U, Schulte-Altedorneburg G, Brueckmann HJ. Dynamic CT perfusion imaging of acute stroke. Am J Neuroradiol 2000; 21: 1441-1449.
17. Cianfoni A, Colosimo C, Basile M, Wintermark M, Bonomo L. Brain perfusion CT: principles, technique and clinical applications. Radiol Med 2007; 112: 1225-1243.
18. Streitparth F, Wieners G, Kämena A, Schröder RJ, Stiepani H, Kokocinski T, Röttgen R, Steinhagen-Thiessen E, LenzenGrossimlimghaus R, Hidajat N. Diagnostic value of multislice perfusion CT in dementia patients. Radiologe 2008; 48: 175- 184.
19. Zimny A, Leszek J, Kiejna A, Sasiadek M. Analysis of correlation between the degree of cognitive impairment and the results of perfusion CT in patients with dementia. Med Sci Monitor 2007; 13: 23-30.
20. Benson DF, Kuhl DE, Hawkins RA, Phelps ME, Cummings JL, Tsai SY. The fluorodeoxyglucose 18F scan in Alzheimers disease and multi-infarct dementia. Arch Neurol-Chicago 1983; 40: 711-714.
21. Minoshima S, Giordani B, Berent S, Frey KA, Foster NL, Kuhl DE. Metabolic reduction in the posterior cingulate cortex in very early Alzheimers disease. Ann Neurol 1997; 42: 85-94.
22. Tang Z, Chen F, Huang J, Shi L, Gong HT, Fu H, Qu Z, Pi X. Low-dose cerebral CT perfusion imaging (CTPI) of senile dementia: diagnostic performance Arch Gerontol Geriat 2013; 56: 61-67.